Literature DB >> 15172465

Is post-systolic motion the optimal ultrasound parameter to detect induced ischaemia during dobutamine stress echocardiography?

Jelena Celutkiene1, George R Sutherland, Aleksandras Laucevicius, Diana Zakarkaite, Alfredas Rudys, Virginija Grabauskiene.   

Abstract

AIMS: Doppler myocardial imaging (DMI) has been suggested as a method of quantifying induced ischaemia during dobutamine stress echocardiography (DSE). The aim of the present study was to investigate both standard systolic and diastolic parameters, but more specifically to address the phenomenon of post-systolic motion (PSM) as a marker of acquired ischaemia during DSE using pulsed-wave DMI. METHODS AND
RESULTS: We examined 60 patients without previous myocardial infarction who underwent DSE. Peak systolic, post-systolic, early and late diastolic velocities were measured at rest and during stress. Myocardial segments (n = 908) were divided into ISCHAEMIC and NON-ISCHAEMIC groups according to the presence of significant angiographic coronary stenosis. ISCHAEMIC segments (n = 357) compared with NON-ISCHAEMIC segments (n = 551) demonstrated a reduced increase of systolic velocity (8.0-12.7 vs 9.3-16.4 cm/s, P < 0.05), prominent PSM (5.8-8.3 vs 0.63-2.1 cm/s, P < 0.000001) and reduced early diastolic velocity (6.5-10.2 vs 7.9-13.2 cm/s, P < 0.04) during stress. The peak velocity of PSM was the most accurate index of induced ischaemia (sensitivity 73-100%, specificity 82-97%) compared to systolic and early diastolic velocities (sensitivity 52-77% and 63-68%, specificity 63-77% and 59-81%, respectively).
CONCLUSION: PSM derived by pulsed-wave DMI during DSE was the most sensitive index of acquired ischaemia compared to other functional DMI indices.

Entities:  

Mesh:

Year:  2004        PMID: 15172465     DOI: 10.1016/j.ehj.2004.04.005

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

1.  Relationship between post-systolic motion during dobutamine stress echocardiography and functional recovery of myocardium after successful percutaneous coronary intervention.

Authors:  Young-Soo Lee; Kee-Sik Kim
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

2.  Post-systolic shortening predicts heart failure following acute coronary syndrome.

Authors:  Philip Brainin; Kristoffer Grundtvig Skaarup; Allan Zeeberg Iversen; Peter Godsk Jørgensen; Elke Platz; Jan Skov Jensen; Tor Biering-Sørensen
Journal:  Int J Cardiol       Date:  2018-11-22       Impact factor: 4.164

3.  Two-dimensional speckle tracking echocardiography derived post systolic shortening in patients with unstable angina and normal left ventricular systolic function.

Authors:  Srinivasan Giridharan; Selvaraj Karthikeyan; Arumugam Aashish; Balasubramaniyan Amirtha Ganesh; Palamalai Arun Prasath; Pandiyan Usha
Journal:  Anatol J Cardiol       Date:  2021-12       Impact factor: 1.596

4.  Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.

Authors:  Patrick M Heck; Stephen P Hoole; Sadia N Khan; David P Dutka
Journal:  Cardiovasc Diabetol       Date:  2010-06-24       Impact factor: 9.951

5.  The tissue Doppler imaging derived post-systolic velocity notch originates at the aortic annulus.

Authors:  Alexandre J Ouss; Robert K Riezebos
Journal:  J Cardiovasc Ultrasound       Date:  2014-03-31

6.  Left Ventricle Phenotyping Utilizing Tissue Doppler Imaging in Premature Infants with Varying Severity of Bronchopulmonary Dysplasia.

Authors:  Eunice Torres; Philip T Levy; Afif El-Khuffash; Hongjie Gu; Aaron Hamvas; Gautam K Singh
Journal:  J Clin Med       Date:  2021-05-20       Impact factor: 4.241

7.  Quantitative approach using multiple single parameters versus visual assessment in dobutamine stress echocardiography.

Authors:  Jelena Celutkiene; Diana Zakarkaite; Viktor Skorniakov; Vida Zvironaite; Virginija Grabauskiene; Jelizaveta Burca; Laura Ciparyte; Aleksandras Laucevicius
Journal:  Cardiovasc Ultrasound       Date:  2012-07-30       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.